rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

The Cooper Companies, Inc.

COO · Nasdaq

Health CareMedical DevicesNot moving yet

COO stood above a rising 150-day average in 10 of the last 52 weekly readings, and has been out of that trend for the last 32 weeks. It is 12.6% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 32
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$5.1M
Insider sales, 12 months
$0
Officials’ trades on record
17
Institutions holding
628 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 10 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$3.6MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

17 disclosed lines: House 14, Senate 1, executive 2; 9 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k5 Jun 2026filed 2 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k29 May 2026filed 8 Jun 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k10 Apr 2026filed 1 Jul 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorbought$1k–$15k27 Mar 2026filed 21 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k10 Dec 2025filed 12 Jan 2026
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08sold$1k–$15k15 May 2025filed 9 Jun 2025
Lori Chavez-DeRemer Executive branch: Office of Government EthicsDepartment of Laborsold$1k–$15k28 Apr 2025filed 9 Sep 2025
Susie Lee House: U.S. House ClerkNV03sold$1k–$15k25 Feb 2020filed 28 Apr 2020
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k30 Aug 2019filed 30 Sep 2019
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k20 Mar 2019filed 8 Apr 2019
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k14 Mar 2019filed 8 Apr 2019
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k24 Jan 2019filed 4 Mar 2019

Insiders

Buy orders, 12 months10
Sale orders, 12 months0
Buyers · sellers7 · 0
WhoDidSharesTraded
Lawrence Erik KurziusDirectorbought10,000at $54.9316 Sep 2026filed 17 Sep 2026
Lawrence Erik KurziusDirectorbought10,000at $53.9214 Sep 2026filed 15 Sep 2026
Walter M. Rosebrough, Jr.Directorbought3,000at $54.2914 Sep 2026filed 15 Sep 2026
Walter M. Rosebrough, Jr.Directorbought7,000at $54.1111 Sep 2026filed 15 Sep 2026
Paul A. KeelDirectorbought4,701.015at $53.1811 Sep 2026filed 15 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders628+2 on the quarter
New · exited114 · 111
Reported value$14.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.reduced · filed 7 Aug 202615,029,453$1.1B-1,588,676−9.6%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202612,758,769$914.9M+39,940+0.3%
STATE STREET CORPadded · filed 7 Aug 20268,892,643$637.7M+124,224+1.4%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20268,669,690$621.7M-51,641−0.6%
BROWNING WEST LPadded · filed 14 Aug 20267,195,428$516.0M+215,899+3.1%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLCreduced · filed 13 Aug 20265,430,282$389.4M-1,186,395−17.9%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20265,359,812$382.9M+48,289+0.9%
FRANKLIN RESOURCES INCadded · filed 13 Aug 20265,096,888$365.5M+229,606+4.7%
GENERATION INVESTMENT MANAGEMENT LLPadded · filed 10 Aug 20264,968,673$356.3M+369,284+8.0%
Jupiter Topco LLCnew · filed 14 Aug 20264,254,267$305.1M+4,254,267
31 Mar 2023 – 30 Jun 2026
24314605Mar 23Dec 23Dec 24Sep 25Jun 26

News

Everyone who traded it

Lawrence Erik Kurzius Company insiderDirector · last 16 Sep 20264 · 0
Walter M. Rosebrough Jr. Company insiderDirector · last 14 Sep 20262 · 0
Paul A. Keel Company insiderDirector · last 11 Sep 20261 · 0
Gilbert Ray Cisneros, Jr. HouseCA31 · last 5 Jun 20263 · 0
Donald J. Trump Executive branchWhite House Office · last 10 Apr 20260 · 1
Barbara Carbone Company insiderDirector · last 1 Apr 20260 · 0
Colleen Jay Company insiderDirector · last 1 Apr 20260 · 0
Cynthia L. Lucchese Company insiderDirector · last 1 Apr 20261 · 0
Maria Rivas Company insiderDirector · last 1 Apr 20261 · 0
Robert S. Weiss Company insiderDirector · last 1 Apr 20264 · 21
Teresa S. Madden Company insiderDirector · last 1 Apr 20260 · 0
Alan Armstrong SenateSenator · last 27 Mar 20261 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Oct 202565.5%
Operating profit marginFY 2025 · to 31 Oct 202516.7%
Free cash flow marginFY 2025 · to 31 Oct 202510.6%
Return on capital employedFY 2025 · to 31 Oct 20256.1%
Cash conversionFY 2025 · to 31 Oct 2025212%
Debt to equityFY 2025 · to 31 Oct 20250.30×
Research spendFY 2025 · to 31 Oct 20254.2%
Share count trendFY 2025 · to 1 Dec 20250.0%
Cash and equivalentsFY 2025 · to 31 Oct 2025$110.6M
Free cash flowFY 2025 · to 31 Oct 2025$433.7M

Analyst forecasts

No analyst forecasts yet.